FREEDOM FORUM: Discussion

Article Image

Business Insider

An experimental drug from Biogen Idec became the first Alzheimer's treatment to significantly slow cognitive decline and reduce what is believed to be brain-destroying plaque in patients with early and mild forms of the disease, according to a small

Make a Comment